Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaoru Tamura

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
NPJ Digital Medicine|May 5, 2026
Comparing artificial intelligence and physician performance in predicting IDH mutation status in gliomaSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Neuro-Oncology Advances|September 22, 2021
Low tumor cell content predicts favorable prognosis in germinoma patientsHirokazu Takami, Kaishi Satomi, Kohei Fukuoka, et al.
Neuro-Oncology|February 9, 2022
Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterpartsHirokazu Takami, Asmaa Elzawahry, Yasin Mamatjan, et al.
Acta Neuropathologica|January 13, 2017
Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomasShintaro Fukushima, Satoshi Yamashita, Hisato Kobayashi, et al.
Neuro-Oncology Advances|December 11, 2024
Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort studyMasayuki Kanamori, Shunsuke Tsuzuki, Ichiyo Shibahara, et al.
Acta Neuropathologica|March 10, 2016
Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapyKoichi Ichimura, Shintaro Fukushima, Yasushi Totoki, et al.
Acta Neuropathologica Communications|August 10, 2016
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomasHideyuki Arita, Kai Yamasaki, Yuko Matsushita, et al.
Acta Neuropathologica Communications|November 24, 2020
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutationsHideyuki Arita, Yuko Matsushita, Ryunosuke Machida, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
NPJ Digital Medicine|May 5, 2026
Comparing artificial intelligence and physician performance in predicting IDH mutation status in gliomaSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Neuro-Oncology Advances|September 22, 2021
Low tumor cell content predicts favorable prognosis in germinoma patientsHirokazu Takami, Kaishi Satomi, Kohei Fukuoka, et al.
Neuro-Oncology|February 9, 2022
Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterpartsHirokazu Takami, Asmaa Elzawahry, Yasin Mamatjan, et al.
Acta Neuropathologica|January 13, 2017
Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomasShintaro Fukushima, Satoshi Yamashita, Hisato Kobayashi, et al.
Neuro-Oncology Advances|December 11, 2024
Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort studyMasayuki Kanamori, Shunsuke Tsuzuki, Ichiyo Shibahara, et al.
Acta Neuropathologica|March 10, 2016
Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapyKoichi Ichimura, Shintaro Fukushima, Yasushi Totoki, et al.
Acta Neuropathologica Communications|August 10, 2016
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomasHideyuki Arita, Kai Yamasaki, Yuko Matsushita, et al.
Acta Neuropathologica Communications|November 24, 2020
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutationsHideyuki Arita, Yuko Matsushita, Ryunosuke Machida, et al.
Pageof 6